# Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular Disease and Dialysis Access

> **NCT07141641** · — · TEMPORARILY_NOT_AVAILABLE · sponsor: **Humacyte, Inc.**

## Conditions studied

- Vascular Diseases
- End Stage Renal Disease on Dialysis

## Interventions

- **BIOLOGICAL:** Acellular Tissue Engineered Vessel (ATEV)

## Key facts

- **NCT ID:** NCT07141641
- **Lead sponsor:** Humacyte, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** TEMPORARILY_NOT_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07141641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07141641, "Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular Disease and Dialysis Access". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT07141641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*